Literature DB >> 19275582

Role of Vpr in HIV-1 nuclear import: therapeutic implications.

Yoko Aida1, Go Matsuda.   

Abstract

The replication of human immunodeficiency virus type 1 (HIV-1) in non-dividing cells, such as terminally differentiated macrophages, critically depends on the import of the viral pre-integration complex (PIC) into the nucleus. Vpr, one of the accessory gene products of HIV-1, plays a key regulatory role in PIC nuclear import in macrophages, although its role in the PIC entry mechanism remains to be clarified. Here, we summarize what is currently known about the nuclear-entry step of HIV-1 replication, mainly focusing on how Vpr functions as the main regulator of HIV-1 nuclear import and how it could facilitate the development of novel inhibitors of this process.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19275582     DOI: 10.2174/157016209787581418

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  11 in total

1.  Neisseria gonorrhoeae enhances HIV-1 infection of primary resting CD4+ T cells through TLR2 activation.

Authors:  Jian Ding; Aprille Rapista; Natalia Teleshova; Goar Mosoyan; Gary A Jarvis; Mary E Klotman; Theresa L Chang
Journal:  J Immunol       Date:  2010-02-10       Impact factor: 5.422

2.  Chicken HS4 insulators have minimal barrier function among progeny of human hematopoietic cells transduced with an HIV1-based lentiviral vector.

Authors:  Naoya Uchida; Kareem N Washington; Coen J Lap; Matthew M Hsieh; John F Tisdale
Journal:  Mol Ther       Date:  2010-10-12       Impact factor: 11.454

3.  A Novel Class of HIV-1 Inhibitors Targeting the Vpr-Induced G2-Arrest in Macrophages by New Yeast- and Cell-Based High-Throughput Screening.

Authors:  Hirotaka Sato; Tomoyuki Murakami; Ryosuke Matsuura; Masako Abe; Seiji Matsuoka; Yoko Yashiroda; Minoru Yoshida; Hirofumi Akari; Yosuke Nagasawa; Masami Takei; Yoko Aida
Journal:  Viruses       Date:  2022-06-16       Impact factor: 5.818

Review 4.  Therapeutic Potential of Spirooxindoles as Antiviral Agents.

Authors:  Na Ye; Haiying Chen; Eric A Wold; Pei-Yong Shi; Jia Zhou
Journal:  ACS Infect Dis       Date:  2016-05-05       Impact factor: 5.084

5.  Viral replication is enhanced by an HIV-1 intersubtype recombination-derived Vpu protein.

Authors:  Cristian De Candia; Constanza Espada; Gabriel Duette; Yanina Ghiglione; Gabriela Turk; Horacio Salomón; Mauricio Carobene
Journal:  Virol J       Date:  2010-10-04       Impact factor: 4.099

6.  Tissue-specific HIV-1 infection: why it matters.

Authors:  Maile Ay Karris; Davey M Smith
Journal:  Future Virol       Date:  2011-07       Impact factor: 1.831

7.  Neuronal apoptosis by HIV-1 Vpr: contribution of proinflammatory molecular networks from infected target cells.

Authors:  Debjani Guha; Pruthvi Nagilla; Carrie Redinger; Alagarsamy Srinivasan; Gerald P Schatten; Velpandi Ayyavoo
Journal:  J Neuroinflammation       Date:  2012-06-22       Impact factor: 8.322

8.  Nuclear exportin receptor CAS regulates the NPI-1-mediated nuclear import of HIV-1 Vpr.

Authors:  Eri Takeda; Tomoyuki Murakami; Go Matsuda; Hironobu Murakami; Tamotsu Zako; Mizuo Maeda; Yoko Aida
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

9.  The human immunodeficiency virus type 1 Vpr protein and its carboxy-terminally truncated form induce apoptosis in tumor cells.

Authors:  Mizuho Nonaka; Yoshie Hashimoto; Shin-Nosuke Takeshima; Yoko Aida
Journal:  Cancer Cell Int       Date:  2009-08-12       Impact factor: 5.722

10.  Visualizing Vpr-induced G2 arrest and apoptosis.

Authors:  Tomoyuki Murakami; Yoko Aida
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.